The Patent Finder

Entrada Therapeutics, Inc.

Also on record
Records under this name other than the patents Entrada Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Back to Entrada Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
17/530,664Cell Penetrating Peptides and Methods of Making and Using Thereof
Abandoned
Abandoned Jul 25, 2024
AbandonedAbandoned Jul 25, 2024
17/739,943Antigen-Binding and Antigen Degradation Constructs
Abandoned
Abandoned Dec 23, 2025
AbandonedAbandoned Dec 23, 2025
18/128,669Cyclic Cell Penetrating Peptides
Abandoned
Abandoned Jun 29, 2026
AbandonedAbandoned Jun 29, 2026
18/238,725Methods for the Sequencing of Phosphorodiamidate Morpholino Oligomers (PMO) and Peptide-Pmo (PPMO) Conjugates
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/289,943Compositions and Methods for Modulating Interferon Regulatory FACTOR-5 (IRF-5) Activity
Abandoned
Abandoned Oct 9, 2026
AbandonedAbandoned Oct 9, 2026
18/289,944Compositions and Methods for Modulating Gene Expression
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/289,946COMPOSITIONS AND METHODS FOR MODULATING mRNA SPLICING
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/390,717Antisense Compounds and Methods for Targeting Cug Repeats
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/506,057Cyclic Cell Penetrating Peptides
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/553,379Cyclic Cell Penetrating Peptides
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 24 records shown.
Pro members see all 24.
Pro members: see all 24 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited